Nucleic Acids Research · 2024 · 13 citations · 59 references
Life SciencesMolecular BiologyMolecular GeneticsGene DeliveryGenetic EngineeringGenome EditingCrispr-cas SystemsDelivery Systems For Genome EditingGene Delivery VectorsGene Editing Payload DeliveryIn Vivo Gene DeliveryViral Vector-mediated TransgenesisAdeno-associated Viral VectorsCrispr-cas Genome EditingCrispr-cas9 Genome EditingDelivery Systems For CrisprGene Editing Delivery VectorsGenome Editing Via Viral VectorsNonhomologous End JoiningViral Vector Delivery
Genome editing based on programmable nucleases and donor DNA constructs permits introducing specific base-pair changes and complete transgenes or live-cell reporter tags at predefined chromosomal positions. A crucial requirement for such versatile genome editing approaches is, however, the need to co-deliver in an effective, coordinated and non-cytotoxic manner all the required components into target cells. Here, adenoviral (AdV) and adeno-associated viral (AAV) vectors are investigated as delivery agents for, respectively, engineered CRISPR-Cas9 nucleases and donor DNA constructs prone to homologous recombination (HR) or homology-mediated end joining (HMEJ) processes. Specifically, canonical single-stranded and self-complementary double-stranded AAVs served as sources of ectopic HR and HMEJ substrates, whilst second- and third-generation AdVs provided for matched CRISPR-Cas9 nucleases. We report that combining single-stranded AAV delivery of HR donors with third-generation AdV transfer of CRISPR-Cas9 nucleases results in selection-free and precise whole transgene insertion in large fractions of target-cell populations (i.e. up to 93%) and disclose that programmable nuclease-induced chromosomal breaks promote AAV transduction. Finally, besides investigating relationships between distinct AAV structures and genome-editing performance endpoints, we further report that high-fidelity CRISPR-Cas9 nucleases are critical for mitigating off-target chromosomal insertion of defective AAV genomes known to be packaged in vector particles.
59
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker, Linyi Gao, Bernd Zetsche et al. · Science · 2015 · 2.5K citations
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki, Yuji Tsunekawa, Reyna Hernández‐Benítez et al. · Nature · 2016 · 1.2K citations · Full text
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
Robert J. Ihry, Kathleen A. Worringer, Max R. Salick et al. · Nature Medicine · 2018 · 1K citations
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever, Rasmus O. Bak, Andreas Reinisch et al. · Nature · 2016 · 876 citations · Full text